While combining two or more antidepressants is reported to
be commonplace in practitioner surveys in many countries, there
is only level 2 evidence to support this strategy for patients who
do not respond adequately to antidepressant monotherapy. The
best available evidence is for add-on treatment with mirtazapine
or bupropion.